Recent
quick returnPopular searches
live pathsNYSE · Healthcare
$28.16
▲ +$0.9100(+3.34%)1:15 PM ET - vs previous closeiQuote as of Aug 19, 2026, 1:15 PM EDT
Realtime NYSE quote as of Aug 19, 2026, 1:15 PM EDT.
Market data source
Chart
Latest 1D session
Trade access
Affiliate disclosure: TECHi may earn a commission on links to broker partners. Read more.
Investor playbook
The current snapshot gives bulls more to work with, but the watch list still controls timing.
Use it for
Entry timing, risk check, and catalyst scan
What has to keep working for US investors to stay interested.
Trend support
+11.9%Current price is above the 200-day average.
Cash yield
6.8%$10.98B free-cash-flow base.
Where the dashboard says the thesis can break or get crowded.
Balance-sheet drag
-38.8%-$62.22B net balance-sheet position.
Catalysts and positioning checks that are not duplicate live-pulse metrics.
Latest catalyst
SeekingAlphaPfizer: Still Cheap Valuation Meets A Looming Patent Cliff
The playbook is derived from quote, analyst, financial, news, and trend snapshots. It is a research workflow aid, not a buy or sell recommendation.
As of Aug 19, 2026, 1:15 PM EDT, Pfizer, Inc. (PFE) traded at $28.16, a +3.34% move versus the prior close, ranging between $27.58 and $28.44 intraday, and on volume of 37.76M shares. The stock has traded between $23.58 and $28.75 over the past 52 weeks, carries a market capitalization of $160.5B, trades at 37.05x trailing earnings, and yields 6.3% in dividends. Sell-side analysts rate PFE Hold across 36 ratings and carry an average price target of $28.61 (+1.58% implied versus the last quote). PFE's record close stands at $61.71, set on Dec 20, 2021.
Hold analyst tone. Latest catalyst: Pfizer: Still Cheap Valuation Meets A Looming Patent Cliff (SeekingAlpha).
Balanced watch. Risk brake (71/100) is the strongest signal; quality trend (17/100) is the main constraint. Model confidence is 51/100 — some inputs are unavailable, so treat this as a directional research screen rather than a forecast. Long-term secular context is tracked separately: Last month +14.9% total; yesterday +3.3%. Comparable past signals have verified against subsequent prices 27.6% of the time.
Expected-return math is scaled by beta and realized volatility before confidence is applied.
Short-horizon expected moves are volume-weighted so thin moves get less credit than confirmed tape.
Sector momentum is included beside the broader market regime.
| Enterprise value | $222.72B |
| Price / book | 1.88 |
| Return on assets | 2.15% |
| EPS (TTM) | $0.76 |
| Beta (5Y) | 0.28 |
Benchmark context
Compare against its sector ETF and the broad market.
Help · FAQ
3 answers covering latest price, analyst view, and sector context.
TECHi displays provider-supplied values only when the corresponding field is present.